Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi AppTec
Pharma
Novartis reviews ties to China amid US biosecurity crackdown
Novartis is taking a proactive approach as it reviews its ties to Chinese contractors in the wake of the U.S. BIOSECURE Act, the company's CFO said.
Fraiser Kansteiner
Apr 23, 2024 11:07am
BIO's top lobbyist heads out the door
Apr 10, 2024 3:22pm
Big Pharma CEOs in China, AstraZeneca, WuXi—Fierce Pharma Asia
Mar 29, 2024 10:10am
WuXi AppTec allegedly handed over client's IP to China: report
Mar 28, 2024 10:21am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
WuXi AppTec presents optimistic guidance amid US security row
Mar 19, 2024 4:27pm